Leila M. Luheshi

Leila M. Luheshi

Auto-generated profile, based on publicly available information

Leila M. Luheshi

Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in Current Opinion in Chemical Biology
Verified
Journal Article
Closed access
LLLeila M Luheshi
Leila M Luheshi
DCDamian C Crowther
Damian C Crowther
CDChristopher M Dobson
Christopher M Dobson

1 April 2010 in Biophysical Journal
Verified
Journal Article
Closed access
ABAnn-Christin Brorsson
Ann-Christin Brorsson
BBBenedetta Bolognesi
Benedetta Bolognesi
Gian Gaetano TartagliaGian Gaetano Tartaglia
Gian Gaetano Tartaglia
SSSarah L. Shammas
Sarah L. Shammas
GFGiorgio Favrin
Giorgio Favrin
LLLeila M. Luheshi
Leila M. Luheshi

22 February 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JGJenna M. Gregory
Jenna M. Gregory
TBTeresa P. Barros
Teresa P. Barros
SMSarah Meehan
Sarah Meehan
CDChristopher M. Dobson
Christopher M. Dobson
LLLeila M. Luheshi
Leila M. Luheshi
Almost all cases of sporadic amyotrophic lateral sclerosis (ALS), and some cases of the familial form, are characterised by the deposition of TDP-43, a member of a family of heteronuclear ribonucleoproteins (hnRNP). Although protein misfolding and deposition is thought to be a causative feature of many of the most prevalent neurodegenerative diseases, a link between TDP-43 aggregation and the dysfunction of motor neurons has yet to be established, despite many correlative neuropathological studies. We have investigated this relationship in the present study by probing the effect of altering TDP-43 aggregation behaviour in vivo by modulating the levels of molecular chaperones in a Drosophila model. More specifically, we quantify the effect of either pharmacological upregulation of the heat shock response or specific genetic upregulation of a small heat shock protein, CG14207, on the neurotoxicity of both TDP-43 and of its disease associated 25 kDa fragment (TDP-25) in a Drosophila model. Inhibition of the aggregation of TDP-43 by either method results in a partial reduction of its neurotoxic effects on both photoreceptor and motor neurons, whereas inhibition of the aggregation of TDP-25 results not only in a complete suppression of its toxicity but also its clearance from the brain in both neuronal subtypes studied. The results demonstrate, therefore, that aggregation plays a crucial role in mediating the neurotoxic effects of both full length and truncated TDP-43, and furthermore reveal that the in vivo propensity of these two proteins to aggregate and their susceptibility to molecular chaperone mediated clearance are quite distinct.

1 June 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ESElena Speretta
Elena Speretta
TJThomas R. Jahn
Thomas R. Jahn
Gian Gaetano TartagliaGian Gaetano Tartaglia
Gian Gaetano Tartaglia
GFGiorgio Favrin
Giorgio Favrin
TBTeresa P. Barros
Teresa P. Barros
CDChristopher M. Dobson
Christopher M. Dobson
The generation and subsequent aggregation of amyloid β (Aβ) peptides play a crucial initiating role in the pathogenesis of Alzheimer disease (AD). The two main isoforms of these peptides have 40 (Aβ40) or 42 residues (Aβ42), the latter having a higher propensity to aggregate in vitro and being the main component of the plaques observed in vivo in AD patients. We have designed a series of tandem dimeric constructs of these Aβ peptides to probe the manner in which changes in the aggregation kinetics of Aβ affect its deposition and toxicity in a Drosophila melanogaster model system. The levels of insoluble aggregates were found to be substantially elevated in flies expressing the tandem constructs of both Aβ40 and Aβ42 compared with the equivalent monomeric peptides, consistent with the higher effective concentration, and hence increased aggregation rate, of the peptides in the tandem repeat. A unique feature of the Aβ42 constructs, however, is the appearance of high levels of soluble oligomeric aggregates and a corresponding dramatic increase in their in vivo toxicity. The toxic nature of the Aβ42 peptide in vivo can therefore be attributed to the higher kinetic stability of the oligomeric intermediate states that it populates relative to those of Aβ40 rather than simply to its higher rate of aggregation.

25 November 2013 in ACS Chemical Biology
Verified
Journal Article
Closed access
BBBenedetta Bolognesi
Benedetta Bolognesi
SCSamuel I. A. Cohen
Samuel I. A. Cohen
PTPablo Aran Terol
Pablo Aran Terol
EEElin Esbjörner
Elin Esbjörner
SGSofia Giorgetti
Sofia Giorgetti
LLLeila M. Luheshi
Leila M. Luheshi

11 April 2014 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
JWJessica Wacker
Jessica Wacker
RRRaik Rönicke
Raik Rönicke
MWMartin Westermann
Martin Westermann
MWMelanie Wulff
Melanie Wulff
KRKlaus G Reymann
Klaus G Reymann
MFMarcus Fändrich
Marcus Fändrich
The self-assembly of Aβ peptides into a range of conformationally heterogeneous amyloid states represents a fundamental event in Alzheimer’s disease. Within these structures oligomeric intermediates are considered to be particularly pathogenic. To test this hypothesis we have used a conformational targeting approach where particular conformational states, such as oligomers or fibrils, are recognized in vivo by state-specific antibody fragments.